Absolutely Sojourner! While anything is possible, you finally mention something no one has, ( I think ). Go ahead, but let's continue follow up testing in some groups to actually see the length of efficacy. PAR mentioned 6 months to a year in between treatments, IF NEEDED. But our past history shows a much longer duration after getting treatment for a lot of folks. Don't forget that we are looking for facts required for labeling as well. Maybe misunderstood... in our thinking.... the "longer trials" do not need to come before we start IND, but after we start.
I don't think that a CR is an issue. The story has been, at that point down the road we would almost definitely sign with a partner for sales and distribution.
Fun guessing things at times, but guessing in Pharma v FDA is waaaaayyyyyyy outta my league. I'll sit in the stands and watch the game and people watch. Of course, the best to all of the crew. Let's start the day off with some positive energy Mates!
PAR Price at posting:
$2.22 Sentiment: Buy Disclosure: Held
(20min delay)